Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.110
-0.060 (-5.13%)
Mar 17, 2026, 4:00 PM EDT - Market closed
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $41.92 million as of March 18, 2026. Its market cap has increased by 17.04% in one year.
Market Cap
41.92M
Enterprise Value
40.30M
1-Year Change
17.04%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $41.92M, an increase of 2,258.22%. That is a compound annual growth rate of 152.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 46.66M | -20.80% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiNK Therapeutics | 44.92M |
| LeonaBio | 44.57M |
| Lite Strategy | 44.00M |
| NextCure | 43.86M |
| Plus Therapeutics | 42.89M |
| Atara Biotherapeutics | 42.77M |
| Chemomab Therapeutics | 42.63M |
| Werewolf Therapeutics | 42.24M |